Skip to main content
. Author manuscript; available in PMC: 2024 Jan 8.
Published in final edited form as: AIDS. 2022 Jul 15;36(12):1697–1705. doi: 10.1097/QAD.0000000000003315

Table 3.

Estimated change in the number of persons who obtained antiretroviral prescriptions for HIV treatment in the United States, March 15, 2020–March 27, 2021.

Average March 2020-March 2021 Relative change % (95% CI) Week 1 March 15–21, 2020 Relative change % (95% CI) 2020 Q2 March 15-June 27, 2020 Relative change % (95% CI) 2020 Q3 June 28-September 26, 2020 Relative change % (95% CI) 2020 Q4 September 27-December 26, 2020 Relative change % (95% CI) 2021 Q1 December 27, 2020-March 27, 2021 Relative change % (95% CI)
Total −4.5 (−6.0, −3.0) 17.8 (16.3, 19.4) −1.2 (−2.7, 0.3) −3.5 (−5.0, −1.9) −6.3 (−7.8, −4.8) −7.4 (−8.9, −5.9)
Sex
 Male −4.5 (−6.4, −2.6) 17.6 (15.6, 19.6) −1.1 (−2.9, 0.8) −3.5 (−5.4, −1.6) −6.4 (−8.2, −4.5) −7.4 (−9.3, −5.5)
 Female −4.6 (−6.3, −2.8) 18.6 (16.8, 20.5) −1.5 (−3.2, 0.2) −3.5 (−5.3, −1.7) −6.1 (−7.8, −4.3) −7.5 (−9.2, −5.7)
Age group (years)
 13–24 −7.9 (−11.9, −3.9) 16.4 (12.3, 20.7) −6.0 (−9.8, −1.9) −6.5 (−10.5, −2.3) −7.4 (−11.4, −3.2) −11.5 (−15.4, −7.5)
 25–34 −11.5 (−14.0, −8.9) 15.1 (12.4, 17.9) −6.2 (−8.8, −3.6) −10.5 (−13.1, −7.9) −13.2 (−15.7, −10.7) −16.0 (−18.4, −13.4)
 35–44 −6.1 (−8.7, −3.4) 20.3 (17.5, 23.1) −1.5 (−4.1, 1.2) −5.1 (−7.8, −2.4) −7.8 (−10.4, −5.2) −10.1 (−12.7, −7.5)
 45–54 −3.7 (−6.4, −1.0) 17.1 (14.4, 19.9) −0.1 (−2.7, 2.6) −2.7 (−5.4, 0.1) −5.8 (−8.4, −3.1) −6.8 (−9.4, −4.0)
 55–64 −3.4 (−6.0, −0.6) 17.9 (15.2, 20.6) −0.7 (−3.3, 2.0) −2.4 (−5.0, 0.4) −5.3 (−7.9, −2.6) −5.4 (−8.1, −2.7)
 ≥65 −3.0 (−5.6, −0.4) 14.9 (12.4, 17.6) −0.9 (−3.4, 1.7) −1.7 (−4.4, 1.0) −4.9 (−7.5, −2.3) −5.0 (−7.6, −2.3)
Race and ethnicitya
 White −2.7 (−5.2, 0.0) 19.5 (16.8, 22.2) −0.8 (−3.3, 1.8) −2.3 (−4.9, 0.4) −4.2 −6.8, −1.6) −3.5 −6.1, −0.8)
 Black −2.9 (−5.6, 0.0) 16.8 (14.0, 19.6) 0.6 (−2.2, 3.4) −2.0 (−4.8, 0.8) −4.7 (−7.4, −1.9) −5.6 (−8.4, −2.8)
 Hispanic −2.2 (−6.0, 1.8) 22.4 (18.3, 26.6) 0.0 (−3.7, 3.9) −1.9 (−5.8, 2.1) −3.0 (−6.8, 1.0) −4.0 (−7.9, 0.0)
 Asian/other 5.6 (0.0, 11.5) 30.6 (24.8, 36.8) 8.2 (2.7, 14.0) 5.1 (−0.6, 11.0) 4.4 (−1.3, 10.3) 4.4 (−1.4, 10.4)
 Unknown −5.7 (−8.0, −3.3) 17.0 (14.5, 19.5) −1.9 (−4.2, 0.5) −4.4 (−6.8, −1.9) −7.6 (−9.9, −5.2) −9.3 (−11.6, −6.9)
Census region
 Northeast −6.9 (−9.2, −4.6) 20.3 (17.8, 22.8) −3.0 (−5.2, −0.7) −6.3 (−8.6, −3.9) −8.8 (−11.0, −6.5) −10.2 (−12.5, −7.9)
 Midwest −5.7 (−8.1, −3.2) 13.7 (11.2, 16.2) −2.9 (−5.3, −0.4) −4.5 (−7.0, −1.9) −6.2 (−8.7, −3.7) −9.3 (−11.7, −6.8)
 South −3.7 (−6.3, −1.0) 16.8 (14.1, 19.6) −0.8 (−3.4, 1.8) −2.2 (−4.9, 0.6) −5.8 (−8.4, −3.1) −6.1 (−8.7, −3.4)
 West −2.8 (−5.2, −0.3) 20.2 (17.7, 22.7) 1.3 (−1.1, 3.8) −2.5 (−4.9, 0.0) −4.4 (−6.8, −2.0) −6.0 (−8.4, −3.5)
Insurance
 Public −1.0 (−3.2, 1.3) 16.4 (14.2, 18.6) 0.0 (−2.2, 2.1) −0.2 (−2.5, 2.1) −1.7 (−3.9, 0.6) −2.2 (−4.4, 0.1)
 Private −4.1 (−6.3, −1.9) 19.7 (17.4, 22.0) −0.3 (−2.4, 1.9) −2.5 (−4.7, −0.2) −5.8 (−8.0, −3.7) −8.2 (−10.3, −6.0)
 Cash −2.1 (−7.7, 3.8) 32.9 (26.4, 39.7) −0.8 (−6.3, 4.9) −3.8 (−9.4, 2.0) −1.8 (−7.4, 4.1) −2.1 (−7.8, 4.0)
 Other/Assistance Programs −9.1 (−11.7, −6.4) 21.9 (19.0, 24.9) −1.6 (−4.3, 1.1) −8.5 (−11.1, −5.7) −13.2 (−15.7, −10.6) −13.6 (−16.1, −11.0)
 Unknown −19.8 (−21.9, −17.7) 9.5 (7.1, 11.9) −11.2 (−13.4, −8.9) −18.5 (−20.7, −16.4) −23.8 (−25.8, −21.8) −25.6 (−27.6, −23.6)

CI, confidence interval.

a

Other race/ethnicity included American Indian or Alaska Native and Native Hawaiian or Other Pacific Islander. Over 67% of persons had missing race and ethnicity information so these estimates might be unstable.

b

Public insurance includes Medicare and Medicaid; other includes federal and state assistance programs, drug manufacturer medication assistance programs, and medication coupon programs.